First in Human, Single Ascending Dose Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The goal of this study is to evaluate the safety and tolerability of single ascending oral doses of INV-101 in healthy adult subjects.
Epistemonikos ID: e1a2519b1f85091337fcb69149dc7cc3a869c238
First added on: May 14, 2024